Lee Eifler is an investor and serial entrepreneur. He has solved major challenges for pharma through first principles logic. He accelerated CV19 therapeutic study recruitment by harmonizing operations at testing facilities with the sites operating clinical studies. He then moved on to solving the participant diversity challenge by creating MACOA, Great Lakes Research Institute (acquired by Flourish Research in 2024) and the Artisan Research Network. Lee’s focus into 2026 is the implementation of AI agents to automate research site functions presently done by CRCs to enable his team to focus on tasks with the highest ROI
